Physicians' Academy for Cardiovascular Education

Delipidation and reinfusion of native HDL: How a machine might be the future for ACS treatment

Oct. 14, 2015

Presentation prepared and held by dr Bryan Brewer (Director of Lipoprotein and Atherosclerosis Research at the Cardiovascular Research Institute, MedStar Research Institute, Washington Hospital Center, Washington, DC, USA) in an Xchange Session during ISA2015.
 Brewer_ISA2015_HDL therapies.pdf (1,9MB)Brewer_ISA2015_HDL therapies.pdf (1,9MB)